Whilst it may not be a huge deal, we thought it was good to see that the Boule Diagnostics AB (publ) (STO:BOUL) President, Jesper Söderqvist, recently bought kr119k worth of stock, for kr59.36 per share. That purchase might not be huge but it did increase their holding by 13%.
The Last 12 Months Of Insider Transactions At Boule Diagnostics
In the last twelve months, the biggest single purchase by an insider was when Independent Chairman of the Board Peter von Ehrenheim bought kr1.1m worth of shares at a price of kr57.00 per share. That means that an insider was happy to buy shares at around the current price of kr59.70. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for Boule Diagnostics share holders is that insiders were buying at near the current price.
While Boule Diagnostics insiders bought shares during the last year, they didn't sell. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Boule Diagnostics is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Insider Ownership of Boule Diagnostics
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Insiders own 12% of Boule Diagnostics shares, worth about kr134m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
What Might The Insider Transactions At Boule Diagnostics Tell Us?
The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Boule Diagnostics. That's what I like to see! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Boule Diagnostics. You'd be interested to know, that we found 1 warning sign for Boule Diagnostics and we suggest you have a look.
But note: Boule Diagnostics may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
When trading Boule Diagnostics or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.